S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   210.98 (-2.54%)
AAPL   273.05 (-6.70%)
FB   191.71 (-2.78%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.41 (-7.11%)
NVDA   252.60 (-5.62%)
BABA   205.05 (-1.77%)
MU   50.58 (-3.42%)
GE   10.38 (-5.21%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.71 (-3.75%)
ACB   1.44 (-4.64%)
NFLX   371.71 (-1.99%)
BAC   29.13 (-4.90%)
DIS   117.97 (-4.37%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   210.98 (-2.54%)
AAPL   273.05 (-6.70%)
FB   191.71 (-2.78%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.41 (-7.11%)
NVDA   252.60 (-5.62%)
BABA   205.05 (-1.77%)
MU   50.58 (-3.42%)
GE   10.38 (-5.21%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.71 (-3.75%)
ACB   1.44 (-4.64%)
NFLX   371.71 (-1.99%)
BAC   29.13 (-4.90%)
DIS   117.97 (-4.37%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   210.98 (-2.54%)
AAPL   273.05 (-6.70%)
FB   191.71 (-2.78%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.41 (-7.11%)
NVDA   252.60 (-5.62%)
BABA   205.05 (-1.77%)
MU   50.58 (-3.42%)
GE   10.38 (-5.21%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.71 (-3.75%)
ACB   1.44 (-4.64%)
NFLX   371.71 (-1.99%)
BAC   29.13 (-4.90%)
DIS   117.97 (-4.37%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   210.98 (-2.54%)
AAPL   273.05 (-6.70%)
FB   191.71 (-2.78%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.41 (-7.11%)
NVDA   252.60 (-5.62%)
BABA   205.05 (-1.77%)
MU   50.58 (-3.42%)
GE   10.38 (-5.21%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.71 (-3.75%)
ACB   1.44 (-4.64%)
NFLX   371.71 (-1.99%)
BAC   29.13 (-4.90%)
DIS   117.97 (-4.37%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 PolarityteAcorda TherapeuticsBrainstorm Cell TherapeuticsChampions OncologyGamida Cell
SymbolNASDAQ:PTENASDAQ:ACORNASDAQ:BCLINASDAQ:CSBRNASDAQ:GMDA
Price Information
Current Price$1.35$1.33$6.76$6.48$4.34
52 Week RangeBuyHoldBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyBuy
Consensus Price Target$12.86$7.07$9.00$12.42$17.50
% Upside from Price Target852.38% upside431.33% upside33.14% upside91.62% upside303.23% upside
Trade Information
Market Cap$38.95 million$63.40 million$232.93 million$75.18 million$105.37 million
Beta1.61.311.341.241.6
Average Volume829,6691,835,4451,029,14529,21216,029
Sales & Book Value
Annual Revenue$1.56 million$192.41 millionN/A$27.07 millionN/A
Price / Sales23.570.33N/A2.78N/A
CashflowN/A$4.29 per shareN/A$0.06 per shareN/A
Price / CashN/A0.31N/A105.07N/A
Book Value$3.36 per share$6.47 per share($0.47) per share$0.19 per share$1.02 per share
Price / Book0.400.21N/A34.11N/A
Profitability
Net IncomeN/A$-272,960,000.00$-23,250,000.00$130,000.00$-52,930,000.00
EPS($4.86)($1.99)($1.06)$0.01($1.69)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/A43.20N/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-141.87%N/A-3.35%N/A
Return on Equity (ROE)-113.53%-22.18%-684.41%-45.46%-181.04%
Return on Assets (ROA)-92.95%-9.19%-265.29%-7.72%-77.00%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.07%0.78%N/A1.62%0.09%
Current Ratio3.65%2.33%0.19%0.86%7.61%
Quick Ratio3.62%2.04%0.19%0.86%7.60%
Ownership Information
Institutional Ownership Percentage28.45%N/A9.17%49.37%22.74%
Insider Ownership Percentage8.38%7.10%21.20%44.30%N/A
Miscellaneous
Employees123474319270
Shares Outstanding27.24 million48.03 million26.23 million11.62 million24.22 million
Next Earnings DateN/A5/7/2020 (Estimated)5/8/2020 (Estimated)3/16/2020 (Estimated)5/5/2020 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel